ziftomenib (KO-539) / University of Michigan, Kura Oncology  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ziftomenib (KO-539) / Kura Oncology
NCT05738538: Expanded Access to Ziftomenib

Available
N/A
NA
ziftomenib
Kura Oncology, Inc.
Acute Lymphoblastic Leukemia, With Appropriate Mutations, Acute Myeloid Leukemia, With NPM1 Mutations
 
 

Download Options